Skip to main content

Table 4 Characteristics of those responding "YES" to Q1 "wheezing", Q4 "coughing", Q5 "asthma", or Q7 "nasal" according to the ECRHS screening questionnaire (n = 184)

From: Population prevalence of asthma and its determinants based on European Community Respiratory Health Survey in the United Arab Emirates

  male
(n = 104)
female
(n = 80)
ALL
n = 184
p
Age in years, mean (SD) 34.0 (15.4) 31.3 (15.7) 32.8 (15.5) 0.247
Age band, n (%)     0.309
   • 19 yr or less 27 (26.0%) 18 (22.5%) 45 (24.5%)  
   • 20 to 44 yr 47 (45.2%) 45 (56.3%) 92 (50.0%)  
   • 45 yr or more 30 (28.8%) 17 (21.3%) 47 (25.5%)  
ECRHS screening questionnaire symptoms within the last 12 months, n (%)     
Wheezing/whistling 68 (65.4%) 57 (67.9%) 125 (66.5%) 0.758
   Wheezing with breathlessness 60 (57.7%) 51 (60.7%) 111 (59.0%) 0.916
   Wheezzing without a cold 59 (56.7%) 39 (46.4%) 98 (52.1%) 0.043*
Woken up with chest tightness 57 (54.8%) 44 (52.4%) 101 (53.7%) 0.770
Woken up by shortness of breath 59 (56.7%) 42 (50.0%) 101 (53.7%) 0.380
Woken up by an attack of coughing 70 (67.3%) 60 (71.4%) 130 (69.1%) 0.634
Attack of asthma 52 (50.0%) 47 (56.0%) 99 (52.7%) 0.464
Currently taking asthma medications 54 (51.9%) 41 (48.8%) 95 (50.5%) 0.769
Nasal allergies (including hay fever) 45 (43.3%) 40 (47.6%) 85 (45.2%) 0.559
  1. "*" Significant p-value